|
May 22
|
Orion to host Capital Markets Day today, 22 May 2025, in Helsinki
|
|
May 21
|
Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
|
|
Mar 11
|
Orion Group Financial Statement documents 2024 and Remuneration Report published
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Julia Macharey
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Hao Pan
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – René Lindell
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Olli Huotari
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Liisa Hurme
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Niclas Lindstedt
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Outi Vaarala
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Satu Ahomäki
|
|
Mar 10
|
Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025
|
|
Mar 10
|
Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku
|
|
Feb 19
|
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
|
|
Feb 19
|
February 2025's Top Stocks That May Be Trading Below Estimated Value
|
|
Jan 2
|
3 Leading Dividend Stocks Yielding Up To 8.5%
|
|
Dec 30
|
Orion and Marinus terminate agreement for ganaxolone in Europe
|